| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 12, 2019 | EVP and CFO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 3,440 | $21.68 | 34,264 | |
| Jul 12, 2019 | EVP and CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | -- | |
| Jul 12, 2019 | SVP/GM, Global Vascular | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,600 | -- | 31,041 | |
| Jul 12, 2019 | SVP/GM, Global Vascular | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 5,158 | $21.68 | 25,883 | |
| Jul 12, 2019 | SVP/GM, Global Vascular | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 30,000 | -- | -- | |
| Jul 12, 2019 | SVP and General Counsel | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,585 | -- | 41,308 | |
| Jul 12, 2019 | SVP and General Counsel | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,185 | $21.68 | 40,123 | |
| Jul 12, 2019 | SVP and General Counsel | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,894 | -- | -- | |
| Jun 28, 2019 | Director | Form 4/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,650 | $10.68 | 87,628 | |
| Jun 28, 2019 | Director | Form 4/A | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 3,607 | $19.69 | 84,021 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.